Leonard Frank X - Jan 5, 2023 Form 4 Insider Report for NovoCure Ltd (NVCR)

Role
President, CNS Cancers US
Signature
By: /s/ Steven Robbins, Attorney in Fact for Frank X. Leonard
Stock symbol
NVCR
Transactions as of
Jan 5, 2023
Transactions value $
-$3,892,957
Form type
4
Date filed
1/9/2023, 05:21 PM
Previous filing
Nov 3, 2022
Next filing
Mar 2, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVCR Ordinary Shares Sale -$279K -2.35K -4.65% $119.01 48.1K Jan 5, 2023 Direct F1
transaction NVCR Ordinary Shares Sale -$45K -417 -0.87% $108.00 47.7K Jan 5, 2023 Direct F2
transaction NVCR Ordinary Shares Sale -$60.5K -526 -1.1% $115.03 47.2K Jan 5, 2023 Direct F3
transaction NVCR Ordinary Shares Sale -$118K -1.01K -2.14% $117.00 46.2K Jan 5, 2023 Direct F2
transaction NVCR Ordinary Shares Options Exercise $112K +7.83K +16.95% $14.37 54K Jan 5, 2023 Direct F2
transaction NVCR Ordinary Shares Sale -$845K -7.83K -14.5% $108.00 46.2K Jan 5, 2023 Direct F2
transaction NVCR Ordinary Shares Options Exercise $86K +7.5K +16.25% $11.46 53.7K Jan 5, 2023 Direct F2
transaction NVCR Ordinary Shares Sale -$810K -7.5K -13.98% $108.00 46.2K Jan 5, 2023 Direct F2
transaction NVCR Ordinary Shares Options Exercise $39.4K +5.52K +11.95% $7.15* 51.7K Jan 5, 2023 Direct F2
transaction NVCR Ordinary Shares Sale -$596K -5.52K -10.68% $108.00 46.2K Jan 5, 2023 Direct F2
transaction NVCR Ordinary Shares Options Exercise $152K +7.18K +15.56% $21.15 53.3K Jan 5, 2023 Direct F2
transaction NVCR Ordinary Shares Sale -$819K -7.18K -13.47% $114.00 46.2K Jan 5, 2023 Direct F4
transaction NVCR Ordinary Shares Options Exercise $152K +7.18K +15.56% $21.15 53.3K Jan 5, 2023 Direct F2
transaction NVCR Ordinary Shares Sale -$862K -7.18K -13.47% $120.00 46.2K Jan 5, 2023 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NVCR Options to Buy Ordinary Shares Options Exercise $0 -7.83K -100% $0.00* 0 Jan 5, 2023 Ordinary Shares 7.83K $14.37 Direct F2, F5
transaction NVCR Options to Buy Ordinary Shares Options Exercise $0 -7.5K -100% $0.00* 0 Jan 5, 2023 Ordinary Shares 7.5K $11.46 Direct F2, F5
transaction NVCR Options to Buy Ordinary Shares Options Exercise $0 -5.52K -100% $0.00* 0 Jan 5, 2023 Ordinary Shares 5.52K $7.15 Direct F2, F5
transaction NVCR Options to Buy Ordinary Shares Options Exercise $0 -7.18K -40.67% $0.00 10.5K Jan 5, 2023 Ordinary Shares 7.18K $21.15 Direct F2, F5
transaction NVCR Options to Buy Ordinary Shares Options Exercise $0 -7.18K -28.91% $0.00 17.7K Jan 5, 2023 Ordinary Shares 7.18K $21.15 Direct F2, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On January 5, 2023, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Leonard, Mr. Leonard sold 2,345 shares in multiple trades at prices ranging from $119.00 to $119.07. The price reported above reflects the weighted average sale price. Mr. Leonard hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected.
F2 Transaction was made pursuant to a Rule 10b-5-1 trading plan adopted by Mr. Leonard.
F3 On January 5, 2023, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Leonard, Mr. Leonard sold 526 shares in multiple trades at prices ranging from $115.00 to $115.59. The price reported above reflects the weighted average sale price. Mr. Leonard hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected.
F4 On January 5, 2023, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Leonard, Mr. Leonard sold 7,183 shares in multiple trades at prices ranging from $114.00 to $114.03. The price reported above reflects the weighted average sale price. Mr. Leonard hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected.
F5 Fully vested as of the date hereof.